65,437 trials
Urinary Incontinence, Stress
Primary: Pain in the Morning — 9.5; 27.0 scores on a scale — p=0.014
Coronary Artery Disease (CAD)
Primary: Extent of Preservation Of Platelet Inhibitory Effect After Transition From Cangrelor To Prasugrel Or Clopidogrel Compared With Effect Observed With Prasugrel Or…
Cataract
Primary: Percent Reduction in Manifest Cylinder — 74.6; 19.9 percent reduction in manifest cylinder
Cancer of the PROSTATE
Primary: The Percentage of Patients Able to be Sexually Active With or Without the Use of Aids — 88 percentage of patients
Freidreich's Ataxia
Primary: Measures of Safety and Tolerability: Nature and Frequency of Adverse Events (AEs) — 188; 109; 8; 54 participants
Metastatic Sarcoma
Primary: Disease Control Rate — 13; 2; 3 Participants
Influenza
Primary: Number of Seroconverted (SCR) Subjects for Hemagglutination Inhibition (HI) Antibodies Against Flu A/California/7/2009 (H1N1) Virus Strain — 60; 44 Participants
Type 1 Diabetes
Primary: Duration of Nocturnal Hypoglycemia — 12.5; 15 minutes — p=0.106
Pain
Primary: Time-weighted Sum of Pain Intensity Difference Scores on 11-Point Numerical Scale From 0 to 24 Hours Post-dose (SPID11 [0-24]) — -8.13; 64.76 units on a Scale — p=<0.001
Mild Hypercortisolism
Primary: A1C Level — 6.2; 6.1375; 6.125 percentage of red blood cells
Maternal Oxygen Use in Labor
Primary: Number of Participants Who Delivered by Cesarean — 83; 75 Participants
Infertility
Primary: Ongoing Pregnancy Rate — 35.5; 30.7 percentage of participants
Influenza
Primary: Geometric Mean Titers (GMTs) of Influenza Vaccine Antibodies — 14.4; 84.1; 107; 44.3 Titers (1/dilutions)
Diabetes
Primary: HBA1c at One Year — 8.5; 7.7; 7.9; 7.9 percentage of HbA1c — p=0.027
Obesity
Primary: Change in Child Body Mass Index (BMI Z-score) — 0.95; 0.99; 0.94; 1.01 z-score